Our Recommendations
- Guidelines forPrevention and Management of Stroke (2019)
- Alzheimer's Disease International. The Global Voice on Dementia (2019)
- Management of physical health conditions in adults with severe mental disorders (2018)
- mhGAP Intervention Guide Mental Health Gap Action Programme Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings (2016)
- Atlas: country resources for neurological disorders 2004: results of a collaborative study of the World Health Organization and the World Federation of Neurology (2004)
New Publications
- Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time (2023)
- Demenz und Migration (2023)
- iSupport for dementia: training and support manual for carers of people with dementia (2022)
- Manual para el entrenamiento y apoyo de cuidadores de personas con demencia: manual completo (2022)
- Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031 (2022)
Filter
225
Featured
Recommendations
15
New Publications
11
Language
Document type
No document type
204
Training Material
7
Fact sheets
4
Studies & Reports
3
Manuals
2
Guidelines
2
Strategic & Response Plan
2
Resource Platforms
1
Countries / Regions
Russia
23
Ukraine
18
Eastern Europe
14
Africa
12
Western and Central Europe
12
India
9
Global
5
Latin America and the Carribbean
4
Germany
3
Uganda
3
South Sudan
3
Nepal
2
Syria
2
Nigeria
2
Estonia
2
Congo, Democratic Republic of
2
Australia
1
China
1
Chile
1
Iran
1
USA
1
Asia
1
South–East Asia Region
1
Brazil
1
Authors & Publishers
Publication Years
Category
Age & Elderly
15
Guidelines
5
Neurology & Psychology
5
Vaccine-preventable Diseases
3
Training Manuals
3
Cardiovascular Diseases
2
Mental Health
2
Communicable Diseases
1
Diabetes
1
Online Courses & Platforms
1
Neurology & Psychology
1
Humanitarian Aid
1
Policies
1
Women & Child Health
1
Disabilities
1
Studies & Reports
1
Communicable Diseases
1
Neonatal Care
1
Toolboxes
Neurological Disorders
127
Alzheimer's Disease & Dementia
69
Epilepsy
59
Neurological disorders, Others
37
Epilepsy
22
Meningitis & Encephalitis
19
IEC Material Neurological Disorders
18
Stroke
17
Children/Adolescents Mental Disorders
14
Training Supporting Material mhGAP
13
Mental Health GAP Action Programme
10
Mental Disorders
7
Depression
7
Eastern Europe
6
General Studies & Reports
6
others
6
Africa
5
mhGAP Guides
5
Substance Use Disorders & Addiction
5
Latin America
4
Meningitis Prevention & Control
3
Asia
3
Modules
3
Training & Capacity Building
3
Schizophrenia
2
Latin America
2
Public Health
2
Africa
2
Mental Health
2
Health & Refugee
2
Women's Mental Health
2
Others
2
Asia
2
Self-harm & Suicide
2
Psychosocial Support
2
Learning Disabilities
2
Psychosocial Support
2
War & Conflict
1
Clinical Guidelines
1
Global Mental Health
1
Plague
1
Neuropsychology of Trauma
1
Training Manuals
1
Influenza
1
General Mental Health Guidelines
1
Videos & Online Courses
1
Stigma & Discrimination
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Studies & Reports
1
Ebola & Marburg
1
Mental Health Studies & Reports
1
Mental Health Guidelines
1
Mental Health Online Resources
1
Psychosocial Support
1
Self-care
1
MPOX - Monkeypox
1
Zika
1
Bipolar Affective Disorders
1
Mental Health
1
IEC Materials Children
1
Anxiety Disorders
1
Community-based Mental Health Care
1
Chikungunya
1
The report “Dementia: a public health priority” has been jointly developed by WHO and Alzheimer's Disease International. The purpose of this report is to raise awareness of dementia as a public health priority, to articulate a public health approach and to advocate for action at international a...
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo...
Q 7: For adults and children with convulsive epilepsy, which standard antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, valproic acid) when compared to placebo/a comparator produce benefits/harm in the specified outcomes?
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Q9: For carers of people with dementia, do interventions (psychoeducational, cognitive-behavioural therapy counseling/case management, general support, training of caregivers, multi-component interventions and miscellaneous interventions) when compared to placebo/comparator, produce benefits/harm in...
Q8: For people with dementia, what is the role of a medical review (including comorbid physical and mental conditions and medication use)?
Q4: For people with dementia with associated depression, do antidepressants when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Q2: For people with dementia, does memantine, when compared to placebo/comparator, produce benefits/harm in the specified outcomes in non-specialist health settings?
Q7: For people with dementia, who should be told of the diagnosis and how should the diagnosis be delivered?
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Epilepsy is one of the world’s most common chronic neurological disorders. Roughly 50 million people
suffer from it, 5 million of them in the Region of the Americas . Nevertheless, it is estimated that over
50% of these people in Latin America and the Caribbean have no access to services. Furthe...
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
Q4: Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?
Q11: 11a). In women with epilepsy, should antiepileptic therapy be prescribed as monotherapy or polytherapy to decrease the risk of fetal malformations?
11b). Does the use of folic acid preconceptually decrease the risk of foetal malformations in women with epilepsy?
11c). Do phenytoin, phenobarbi...
В методических рекомендациях представлены современные подходы к терапии поведенческих и психотических расстройств у пациентов с болезнью Альцгеймера. Ведение т...
Цель: анализ уровня тревожности и тяжести депрессии у больных рассеянным склерозом. Материал и методы. Чтобы определить уровень депрессии и тревожности у больных ...
